Evidence map›Paper›PMID 34018899›Full record

ArticleExpert review of proteomics2021

Evolution of proteomics technologies for understanding respiratory syncytial virus pathogenesis.

Morgan Mann, Allan R Brasier

Open access · bronzeAbstract read
In one paragraph

Article in Expert review of proteomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Morgan MannDepartment of Internal Medicine, University of Wisconsin-Madison School of Medicine and Public Health (SMPH), Madison, WI, USA.
Allan R BrasierDepartment of Internal Medicine and Institute for Clinical and Translational Research (ICTR), University of Wisconsin-Madison, Madison, WI, USA.
University of Wisconsin–Madison · US

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
Virus, Tissue Culture and ImmunoassayP01AI062885 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI GAROFALO, ROBERTO P · 2005 to 2022
$23.9M
Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic AsthmaU01AI136994 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI BRASIER, ALLAN R., CALHOUN, WILLIAM J · 2019 to 2023
$3.4M
NCATS NIH HHS UL1 TR002373NIAID NIH HHS P01 AI062885NIAID NIH HHS U01 AI136994
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Respiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsChromatography, LiquidHumansProteomeProteomicsProteomeimmunoprecipitation-MSliquid chromatography (LC)-mass spectrometry (MS)respiratory syncytial virus (RSV)

Identifiers

PMID34018899
PMCPMC8277732
OpenAlexW3161649302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.